SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

Economic Value Demonstrated with the SYNERGY Bioabsorbable Polymer (BP) Stent

Today’s healthcare environment is focused on reducing costs and readmissions. The SYNERGY BP Stent was designed to decrease late events through improved healing and exceptional acute performance. Inpatient reimbursement is higher when successfully completing DES PCI.

SYNERGY BP Stent System delivered in 87.1% of cases after other DES failed to deliver.¹

Fast Facts Sign Up

Indications, Safety, and Warnings

Frequently Asked Questions

Request a Sales Rep

SYNERGY BP Stent System May Increase Likelihood of a Successful PCI¹

In a study of 116 PCI cases* where 2nd generation drug eluting stents (Xience™, Resolute Integrity™ and Promus Element™ Stents) were unsuccessfully deployed, the SYNERGY BP Stent was then utilized as a bailout option, delivering in 87.1% (101) of these cases.¹

Key features that enhance the acute performance of SYNERGY BP Stent:

Short red tip improves flexibility and visibility
Bi-Segment™ Inner Lumen Catheter to provide outstanding flexibility and pushability**
Dual-layer PEBAX™ Balloon for optimal compliance and minimal balloon growth
Lowest stent profile**
Monorail™ Port
Laser-cut hypotube for improved pushability and trackability**

Helping Save Time, Improve Efficiency, and Reduce Radiation

According to a survey of European users who compared DES to the SYNERGY BP Stent System in a typical PCI, the SYNERGY BP Stent System provided the following efficiencies:

In a blinded perception study about the SYNERGY BP Stent’s visibility, respondents believed that the SYNERGY BP Stent’s Platinum Chromium alloy could provide the following efficiencies: